A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Banner MD Anderson Cancer Center, Gilbert, Arizona, United States

Mayo Clinic, Phoenix, Arizona, United States

University of Arizona, Tucson, Arizona, United States

John Wayne Cancer Institute (JWCI), Santa Monica, California, United States

Sarah Cannon Research Institute (SCRI), Denver, Colorado, United States

Yale University Hospital, New Haven, Connecticut, United States

Mayo Clinic Jacksonville, Jacksonville, Florida, United States

Moffitt Cancer Center - McKinley Drive, Tampa, Florida, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Henry Ford Health, Detroit, Michigan, United States

Mayo Clinic, Rochester, Minnesota, United States

NYU Langone Health Perlmutter Cancer Center, New York, New York, United States

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Columbia University - The Trustees of Columbia University in the City of New York, New York, New York, United States

Montefiore Medical Center, New York, New York, United States

University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center) - Rochester, Rochester, New York, United States

James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States

Providence Portland Medical Center, Portland, Oregon, United States

Oregon Health & Science University (3485 S. Bond), Portland, Oregon, United States

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Lifespan Cancer Institute, Providence, Rhode Island, United States

MD Anderson Cancer Center, Houston, Texas, United States

Emily Couric Clinical Cancer Center, Charlottesville, Virginia, United States

West Virginia University, Morgantown, West Virginia, United States